Sfoglia per Autore
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma
2015-01-01 Coco, Simona; Truini, Anna; Vanni, Irene; Genova, Carlo; Rosano, Camillo; Dal Bello, Maria Giovanna; Alama, Angela; Venè, Roberta; Rijavec, Erika; Barletta, Giulia; Biello, Federica; Boccardo, Francesco; Grossi, Francesco
Expression of ribonucleotide reductase subunit-2 and thymidylate synthase correlates with poor prognosis in patients with resected stages I-III non-small cell lung cancer
2015-01-01 Grossi, Francesco; Dal Bello, Maria Giovanna; Salvi, Sandra; Puzone, Roberto; Pfeffer, Ulrich; Fontana, Vincenzo; Alama, Angela; Rijavec, Erika; Barletta, Giulia; Genova, Carlo; Sini, Claudio; Ratto, Giovanni Battista; Taviani, Mario; Truini, Mauro; Merlo, Domenico Franco
Belagenpumatucel-L for the treatment of non-small cell lung cancer
2015-01-01 Rijavec, Erika; Biello, Federica; Genova, Carlo; Barletta, Giulia; Maggioni, Claudia; Dal Bello, Maria Giovanna; Coco, Simona; Truini, Anna; Vanni, Irene; Alama, Angela; Beltramini, Sabrina; Grassi, Maria Attilia; Boccardo, Francesco; Grossi, Francesco
Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine.
2015-01-01 Coco, S; Truini, A; Vanni, Irene; Dal Bello, Mg; Alama, A; Rijavec, E; Genova, C; Barletta, G; Sini, C; Burrafato, G; Biello, F; Boccardo, Francesco; Grossi, F.
Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma
2016-01-01 Truini, A.; Coco, S.; Genova, C.; Mora, M.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Rijavec, E.; Barletta, G.; Biello, F.; Maggioni, C.; Grossi, F.
Vinflunine for the treatment of non-small cell lung cancer
2016-01-01 Genova, C.; Alama, A.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Vanni, I.; Biello, F.; Barletta, G.; Rossi, G.; Grossi, F.
Recent advances in squamous non-small cell lung cancer: Evidence beyond predictive biomarkers
2016-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Clinical potential of necitumumab in non-small cell lung carcinoma
2016-01-01 Genova, C.; Hirsch, F. R.
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples
2016-01-01 Bonfiglio, S.; Vanni, I.; Rossella, V.; Truini, A.; Lazarevic, D.; Dal Bello, M. G.; Alama, A.; Mora, M.; Rijavec, E.; Genova, C.; Cittaro, D.; Grossi, F.; Coco, S.
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
2016-01-01 Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco
Heterogeneity of EGFR aberrations and correlation with histological structures: Analyses of therapy-naive isogenic lung cancer lesions with EGFR mutation
2016-01-01 Suda, K.; Murakami, I.; Yu, H.; Ellison, K.; Shimoji, M.; Genova, C.; Rivard, C. J.; Mitsudomi, T.; Hirsch, F. R.
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report
2016-01-01 Vanni, I.; Coco, S.; Bonfiglio, S.; Cittaro, D.; Genova, C.; Biello, F.; Mora, M.; Rossella, V.; Dal Bello, M. G.; Truini, A.; Banelli, B.; Lazarevic, D.; Alama, A.; Rijavec, E.; Barletta, G.; Grossi, F.
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
2016-01-01 Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F.
Hematopoietic growth factors in lung cancer
2016-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
2017-01-01 Truini, A.; Coco, S.; Nadal, E.; Genova, C.; Mora, M.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Rijavec, E.; Biello, F.; Barletta, G.; Merlo, D. F.; Valentino, A.; Ferro, P.; Ravetti, G. L.; Stigliani, S.; Vigani, A.; Fedeli, F.; Beer, D. G.; Roncella, S.; Grossi, F.
Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: Can we use enemy territory at our advantage?
2017-01-01 Genova, C.; Rijavec, E.; Grossi, F.
Palliative treatment of life-threatening hemoptysis with silicone stent insertion in advanced lung cancer
2017-01-01 Barisione, E.; Genova, C.; Grosso, M.; Pasquali, M.; Blanco, A.; Felletti, R.; Salio, M.
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study
2017-01-01 Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
2017-01-01 Grossi, F.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Maggioni, C.; Burrafato, G.; Sini, C.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J.
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy
2017-01-01 Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma | 1-gen-2015 | Coco, Simona; Truini, Anna; Vanni, Irene; Genova, Carlo; Rosano, Camillo; Dal Bello, Maria Giovanna; Alama, Angela; Venè, Roberta; Rijavec, Erika; Barletta, Giulia; Biello, Federica; Boccardo, Francesco; Grossi, Francesco | |
| Expression of ribonucleotide reductase subunit-2 and thymidylate synthase correlates with poor prognosis in patients with resected stages I-III non-small cell lung cancer | 1-gen-2015 | Grossi, Francesco; Dal Bello, Maria Giovanna; Salvi, Sandra; Puzone, Roberto; Pfeffer, Ulrich; Fontana, Vincenzo; Alama, Angela; Rijavec, Erika; Barletta, Giulia; Genova, Carlo; Sini, Claudio; Ratto, Giovanni Battista; Taviani, Mario; Truini, Mauro; Merlo, Domenico Franco | |
| Belagenpumatucel-L for the treatment of non-small cell lung cancer | 1-gen-2015 | Rijavec, Erika; Biello, Federica; Genova, Carlo; Barletta, Giulia; Maggioni, Claudia; Dal Bello, Maria Giovanna; Coco, Simona; Truini, Anna; Vanni, Irene; Alama, Angela; Beltramini, Sabrina; Grassi, Maria Attilia; Boccardo, Francesco; Grossi, Francesco | |
| Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine. | 1-gen-2015 | Coco, S; Truini, A; Vanni, Irene; Dal Bello, Mg; Alama, A; Rijavec, E; Genova, C; Barletta, G; Sini, C; Burrafato, G; Biello, F; Boccardo, Francesco; Grossi, F. | |
| Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma | 1-gen-2016 | Truini, A.; Coco, S.; Genova, C.; Mora, M.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Rijavec, E.; Barletta, G.; Biello, F.; Maggioni, C.; Grossi, F. | |
| Vinflunine for the treatment of non-small cell lung cancer | 1-gen-2016 | Genova, C.; Alama, A.; Coco, S.; Rijavec, E.; Dal Bello, M. G.; Vanni, I.; Biello, F.; Barletta, G.; Rossi, G.; Grossi, F. | |
| Recent advances in squamous non-small cell lung cancer: Evidence beyond predictive biomarkers | 1-gen-2016 | Genova, C.; Rijavec, E.; Grossi, F. | |
| Clinical potential of necitumumab in non-small cell lung carcinoma | 1-gen-2016 | Genova, C.; Hirsch, F. R. | |
| Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples | 1-gen-2016 | Bonfiglio, S.; Vanni, I.; Rossella, V.; Truini, A.; Lazarevic, D.; Dal Bello, M. G.; Alama, A.; Mora, M.; Rijavec, E.; Genova, C.; Cittaro, D.; Grossi, F.; Coco, S. | |
| Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy | 1-gen-2016 | Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco | |
| Heterogeneity of EGFR aberrations and correlation with histological structures: Analyses of therapy-naive isogenic lung cancer lesions with EGFR mutation | 1-gen-2016 | Suda, K.; Murakami, I.; Yu, H.; Ellison, K.; Shimoji, M.; Genova, C.; Rivard, C. J.; Mitsudomi, T.; Hirsch, F. R. | |
| Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report | 1-gen-2016 | Vanni, I.; Coco, S.; Bonfiglio, S.; Cittaro, D.; Genova, C.; Biello, F.; Mora, M.; Rossella, V.; Dal Bello, M. G.; Truini, A.; Banelli, B.; Lazarevic, D.; Alama, A.; Rijavec, E.; Barletta, G.; Grossi, F. | |
| New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer | 1-gen-2016 | Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F. | |
| Hematopoietic growth factors in lung cancer | 1-gen-2016 | Genova, C.; Rijavec, E.; Grossi, F. | |
| Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma | 1-gen-2017 | Truini, A.; Coco, S.; Nadal, E.; Genova, C.; Mora, M.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Rijavec, E.; Biello, F.; Barletta, G.; Merlo, D. F.; Valentino, A.; Ferro, P.; Ravetti, G. L.; Stigliani, S.; Vigani, A.; Fedeli, F.; Beer, D. G.; Roncella, S.; Grossi, F. | |
| Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: Can we use enemy territory at our advantage? | 1-gen-2017 | Genova, C.; Rijavec, E.; Grossi, F. | |
| Palliative treatment of life-threatening hemoptysis with silicone stent insertion in advanced lung cancer | 1-gen-2017 | Barisione, E.; Genova, C.; Grosso, M.; Pasquali, M.; Blanco, A.; Felletti, R.; Salio, M. | |
| Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study | 1-gen-2017 | Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco | |
| Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy | 1-gen-2017 | Grossi, F.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Maggioni, C.; Burrafato, G.; Sini, C.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J. | |
| Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy | 1-gen-2017 | Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile